Litcius/Paper detail

Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK/c-Fos-NFATc1 cascade

Liwei Zhang, Yanjun Yang, Zirui Liao, Qingbai Liu, Xinhuan Lei, Meng Li, Saijilafu, Zunyi Zhang, Dun Hong, Min Zhu, Bin Li, Huilin Yang, Jianquan Chen

2020Theranostics58 citationsDOIOpen Access PDF

Abstract

. Mechanistically, Hh signaling hinders osteoclastogenesis partly through suppressing the JNK/c-Fos-NFATc1 cascade. Thus, Hh signaling may serve as a promising therapeutic target for the prevention and treatment of PPO and other osteolytic diseases.

Topics & Concepts

OsteolysisOsteoclastRANKLBone resorptionChemistrySignal transductionCancer researchHedgehog signaling pathwayOsteoblastCell biologySmoothenedMedicineActivator (genetics)Internal medicineIn vitroBiologyReceptorBiochemistrySurgeryBone health and treatmentsOrthopaedic implants and arthroplastyHedgehog Signaling Pathway Studies
Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK/c-Fos-NFATc1 cascade | Litcius